Drivers of de novo Serine/Glycine synthesis in acute leukemia. | FEBS Lett;597(17): 2145-2146, 2023 09. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Drivers of de novo Serine/Glycine synthesis in acute leukemia.

Verstraete, Paulien; De Keersmaecker, Kim; Kampen, Kim Rosalie.

Affiliation

Verstraete P; Laboratory for Disease Mechanisms in Cancer, Department of Oncology, KU Leuven, Leuven, Belgium.
De Keersmaecker K; Leuven Cancer Institute (LKI), Leuven, Belgium.
Kampen KR; Laboratory for Disease Mechanisms in Cancer, Department of Oncology, KU Leuven, Leuven, Belgium.

FEBS Lett ; 597(17): 2145-2146, 2023 09.

Article in En | MEDLINE | ID: mdl-37526379

Subject(s)
Key words

ALL; AML; DNMT3A; FLT3-ITD; NKX2-1; NOTCH1; RPL10; glycine; serine; sertraline

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute Limits: Humans Language: En Journal: FEBS Lett Year: 2023 Document type: Article Affiliation country:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute Limits: Humans Language: En Journal: FEBS Lett Year: 2023 Document type: Article Affiliation country: